MMSL 2020, 89(2):99-107 | DOI: 10.31482/mmsl.2020.003

DEFINITION OF THE TARGET POPULATION FOR EXTERNAL PACEMAKER AS A KEY ASPECT IN SUCCESSFUL MEDICAL DEVICE HTA PROCESSReview article

Jan Honegr ORCID...1*, Daniel Jun ORCID...1, Kamil Kuca ORCID...2, Petra Maresova ORCID...2
1 Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 12 Hradec Kralove, Czech Republic
2 Faculty of Informatics and Management, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic

In this paper we have compiled and summarized the steps which manufacturers and clinical investigators need to undertake to perform a target population definition during the Health technology assessment process of medical device, namely external cardio stimulator (pacemaker). Based on available data using top-down approach we have defined target population for external cardiostimulator and estimated, that the size of the target population for external pacing will not exceed 16000 patients per year in the Czech Republic and is of comparable size with other states in the region.

Keywords: HTA; Medical Devices; target population; external pacemaker; policymaking

Received: December 30, 2019; Revised: January 28, 2020; Accepted: January 28, 2020; Prepublished online: February 10, 2020; Published: June 5, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Honegr, J., Jun, D., Kuca, K., & Maresova, P. (2020). DEFINITION OF THE TARGET POPULATION FOR EXTERNAL PACEMAKER AS A KEY ASPECT IN SUCCESSFUL MEDICAL DEVICE HTA PROCESS. MMSL89(2), 99-107. doi: 10.31482/mmsl.2020.003
Download citation

References

  1. Ciani O, Wilcher B, van Giessen A, Taylor RS. Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments. Health Economics. 2017;26(S1):13-29. Go to original source... Go to PubMed...
  2. Gupta SK. Medical Device Regulations: A Current Perspective. Journal of Young Pharmacists. 2016;8(1). Go to original source...
  3. Chen YJ, Chiou CM, Huang YW, Tu PW, Lee YC, Chien CH. A Comparative Study of Medical Device Regulations: US, Europe, Canada, and Taiwan. Therapeutic Innovation & Regulatory Science. 2018;52(1):62-9. Go to original source... Go to PubMed...
  4. Bernasconi S. How MDR and IVDR are reshaping Europe's medtech industry. Pulse of the Industry [Internet]. 2017:[28-9 pp.].
  5. Banta D, Jonsson E. History of HTA: Introduction. International Journal of Technology Assessment in Health Care. 2009;25:1-6. Go to original source... Go to PubMed...
  6. World Health Organization. Health Technology Assessment of Medical Devices: World Health Organization; 2012 [Available from: https://books.google.cz/books?id=5JnUkQEACAAJ.
  7. ČESKÁ SPOLEČNOST PRO FARMAKOEKONOMIKU A HODNOCENÍ ZDRAVOTNICKÝCH TECHNOLOGIÍ. Doporučené postupy ČFES pro zdravotně-ekonomická hodnocení v ČR [Available from: https://farmakoekonomika.cz/doporucene-postupy-cfes-pro-zdravotne-ekonomicka-hodnoceni-v-cr/.
  8. John RM. Indications for Permanent and Temporary Cardiac Pacing 2014 [updated 2014/02/05. 1-33]. Available from: https://doi.org/10.1002/9781118459553.ch1. Go to original source...
  9. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). European Heart Journal. 2013;34(29):2281-329. Go to original source... Go to PubMed...
  10. Silbernagl S, Despopoulos A, Gay R, Rothenburger A. Atlas fyziologie člověka : 6. vydání, zcela přepracované a rozšířené. Vyd. 3. české ed. Praha: Grada; 2004. 435 s. p.
  11. Kalahasty G, Kapa S, Cooper JM. Components of a Pacing and ICD System: Basic Concepts of Pacing: Willey; 2014 [updated 2014/02/05. 34-81]. Available from: https://doi.org/10.1002/9781118459553.ch2. Go to original source...
  12. Sovari AA, Zarghamravanbakhsh P, Shehata M. 43 - Temporary Cardiac Pacing Philadelphia: Content Repository Only!; 2019 [updated 2019/01/01/. 456-60]. Available from: http://www.sciencedirect.com/science/article/pii/B9780323529938000436. Go to original source...
  13. Zdravotnické prostředky - RZPRO (Národní registr zdravotnických prostředkù).
  14. Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR, et al. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay. Journal of the American College of Cardiology. 2019;74(7):E51-E156. Go to original source... Go to PubMed...
  15. ÚZIS. ZDRAVOTNICTVÍ ČR: Stručný přehled činnosti oboru anesteziologie a intenzivní medicína za období 2007-2015 NZIS REPORT č. K/10 (09/2016) Prague: UZIS; 2016 [Available from: https://www.uzis.cz/system/files/NZIS_REPORT_c_K10_09_16_A025_anesteziologie_intenzivni_medicina.pdf.
  16. Mond HG, Proclemer A. The 11th World Survey of Cardiac Pacing and Implantable Cardioverter-Defibrillators: Calendar Year 2009-A World Society of Arrhythmia's Project. Pace-Pacing and Clinical Electrophysiology. 2011;34(8):1013-27. Go to original source... Go to PubMed...
  17. Mond HG, Irwin M, Ector H, Proclemer A. The world survey of cardiac pacing and cardioverter-defibrillators: Calendar year 2005 - An International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pace-Pacing and Clinical Electrophysiology. 2008;31(9):1202-12. Go to original source... Go to PubMed...
  18. Mond HG, Irwin M, Morillo C, Ector H. The world survey of cardiac pacing and cardioverter defibrillators: Calendar year 2001. Pace-Pacing and Clinical Electrophysiology. 2004;27(7):955-64. Go to original source... Go to PubMed...
  19. Mond HG. The world survey of cardiac pacing and cardioverter defibrillators: Calendar year 1997. Pace-Pacing and Clinical Electrophysiology. 2001;24(5):869-70. Go to original source... Go to PubMed...
  20. Raatikainen MJP, Arnar DO, Merkely B, Nielsen JC, Hindricks G, Heidbuchel H, et al. A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report fromthe European Heart RhythmAssociation. Europace. 2017;19:1-90. Go to original source... Go to PubMed...
  21. Raatikainen MJP, Arnar DO, Zeppenfeld K, Merino JL, Levya F, Hindriks G, et al. Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association. Europace. 2015;17:I1-I75. Go to original source... Go to PubMed...
  22. Doyle DJ, Garmon EH. American Society of Anesthesiologists Classification (ASA Class). Treasure Island (FL):: StatPearls Publishing; Updated 2019 May 13. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441940/.
  23. ÚZIS. ZDRAVOTNICTVÍ ČR: Stručný přehled činnosti oboru anesteziologie a intenzivní medicína za období 2007-2015 NZIS REPORT č. K/10 (09/2016) Prague: UZIS; 2016 [Available from: https://www.uzis.cz/system/files/NZIS_REPORT_c_K10_09_16_A025_anesteziologie_intenzivni_medicina.pdf.
  24. Česká kardiologická společnost. Národní registry výkonů v arytmologii [Available from: http://www.kardio-cz.cz/narodni-registry-vykonu-v-arytmologii-224/.
  25. Mond HG. The world survey of cardiac pacing and cardioverter-defibrillators: Lessons learnt. Journal of Interventional Cardiac Electrophysiology. 2006;17(3):211-4. Go to original source... Go to PubMed...